The purpose of this review is to collate and summarize some of the available scientific data regarding potential causes, aggravations and therapies in the Fibromyalgia / Chronic Fatigue (FMS/CFS) and like syndromes. This review is not intended to be encyclopedic in its scope but rather to give some data driven rationale for common therapies clinically recognized as useful in these syndromes. Additionally, the data presented are limited to injection therapies (although if absorption is sufficient most of these compounds are known to help as oral supplements as well).
Ascorbic Acid (Vitamin C) is seemingly so ubiquitous an intervention in integrative healthcare it is easy to overlook its potential therapeutic benefit as well as economical cost profile when considering therapies. One therapeutic target that is both common and often filled with costly interventions is cardiovascular prevention and disease.
This 2016 paper and the others noted below reminded me personally of the profound benefit vitamin C can add to cardiovascular prevention and therapy.
Read More
Intravenous ascorbic acid (IVAA) is a well-known intervention in medicine, which currently is rarely used in US hospitals. Due to the unusual and extreme clinical demands of hospitalized COVID-19 patients, IVAA has been implemented in Chinese hospitals, and data published by the “Expert Group on Clinical Treatment of New Corona Virus Disease in Shanghai” (Shanghai, 2019) details the use of IVAA as safe and effective adjunctive care of hospitalized COVID-19 patients. In the IVAA treated group, there was no mortality, no reported side effects, and shorter hospital stays universally.
Read More
Abstract: This presentation focuses on the role of ascorbate (vitamin C) in the treatment of COVID-19 and and its potentially fatal sequela. Pharmacokinetics, safety, and the current scientific literature are reviewed. Clinical applications of oral and intravenous vitamin C are discussed in the context of viral illness.
Read More
